Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Molecular pharmacology 83, 822834, doi: 10.1124/mol.112.084525 (2013)
What the trial record covers The programs to consult include STEP and SUSTAIN for semaglutide, SURMOUNT and SURPASS for tirzepatide, AWARD for dulaglutide, and LEAD and LEADER for liraglutide
Le-Le L, Han Yu, Zi-Jia Z et al (2023) Loss of DJ-1 function contributes to Parkinsons disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation
Cells were treated with two well known depleting agents, diethyl maleate (DEM) and buthionine sulfoximine (BSO), and the cellular and nuclear glutathione levels were assessed by analytical and confocal microscopic techniques, respectively
What format is the medication
10.6004/jnccn.2018.0055
US$ 29.15
US$ 27.00
US$ 20.62
US$ 24.98
